Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis

被引：26

作者：

Gruber, S

Stadlbauer, A

Mlynarik, V

Gatterbauer, B

Roessler, K

Moser, E

机构：

[1] Med Univ Vienna, Magnet Resonance Ctr Excellence, A-1090 Vienna, Austria

[2] Med Univ Vienna, Dept Med Phys, Kompetenzzentrum Hochfeld MR, MR Holzhaus, A-1090 Vienna, Austria

[3] Med Univ Vienna, Dept Neurosurg, Kompetenzzentrum Hochfeld MR, MR Holzhaus, A-1090 Vienna, Austria

[4] Med Univ Vienna, Dept Radiodiagnost, A-1090 Vienna, Austria

来源：

NEUROSURGERY CLINICS OF NORTH AMERICA | 2005年 / 16卷 / 01期

基金：

奥地利科学基金会;

关键词：

D O I：

10.1016/j.nec.2004.07.004

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The current state of standard tumor diagnostics using contrast-enhanced MRI and biopsy is assessed in this review, and the progress of proton magnetic resonance spectroscopy (MRS) over the last 15 years is discussed. We summarize MRS basics and describe a typical magnetic resonance session for noninvasive routine tumor diagnostics at 1.5 T, including two-dimensional magnetic resonance spectroscopic imaging (MRSI). The results that can be obtained from such procedures are illustrated with clinical examples. Attention is turned to cutting-edge methodologic and clinical research at 3 T, with examples using high-resolution or very short echo-time three-dimensional MRSI. The current status and limitations in proton MRSI are discussed, and we look to the potential of faster data collection and even higher field strength.

引用

页码：101 / +

页数：15

共 90 条

[1]

Alesch F, 1995, Acta Neurochir Suppl, V63, P20

[2]

Arnold D L, 1990, NMR Biomed, V3, P184, DOI 10.1002/nbm.1940030407

[3] High-resolution three-dimensional contrast-enhanced blood oxygenation level-dependent magnetic resonance venography of brain tumors at 3 Tesla:: First clinical experience and comparison with 1.5 Tesla [J].